← Back to Search

Unison Speech Therapy for Aphasia

N/A
Recruiting
Led By Lauryn Zipse, PhD
Research Sponsored by MGH Institute of Health Professions
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Controls must report no history of speech, language, neurological disorders, or stroke
People with aphasia must be at least 6-months post-stroke, and aphasia must be due to stroke
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day study visit
Awards & highlights

Study Summary

This trial is testing whether speaking in unison with another person can help those with aphasia, and what characteristics of speech are most helpful.

Who is the study for?
This trial is for native American English speakers who have aphasia or apraxia due to a stroke at least 6 months ago. Controls with no history of speech, language disorders, neurological disorders, or stroke can also join. Participants must pass hearing, cognition, and auditory comprehension screenings.Check my eligibility
What is being tested?
The study explores the effectiveness of speaking in unison as a treatment for aphasia and apraxia. It aims to identify which aspects of speech improve when patients speak together with someone else and investigates how well their speech aligns with the other speaker.See study design
What are the potential side effects?
There are no direct physical side effects from participating in this trial since it involves non-medical interventions such as speaking exercises. However, participants may experience fatigue or frustration during the tasks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have never had speech, language, neurological disorders, or a stroke.
Select...
I have had aphasia for over 6 months due to a stroke.
Select...
I was a native American English speaker before my stroke.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day study visit
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day study visit for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percent syllables correct
Percent syllables entrained

Trial Design

1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
All participants will repeat sentences under four speech conditions, in a 2x2 design

Find a Location

Who is running the clinical trial?

National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
327 Previous Clinical Trials
178,216 Total Patients Enrolled
36 Trials studying Aphasia
2,599 Patients Enrolled for Aphasia
MGH Institute of Health ProfessionsLead Sponsor
15 Previous Clinical Trials
3,555 Total Patients Enrolled
2 Trials studying Aphasia
28 Patients Enrolled for Aphasia
National Institutes of Health (NIH)NIH
2,685 Previous Clinical Trials
6,930,696 Total Patients Enrolled
8 Trials studying Aphasia
1,702 Patients Enrolled for Aphasia

Media Library

Unison speech Clinical Trial Eligibility Overview. Trial Name: NCT05248295 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this medical experiment permit older individuals to participate?

"According to the enrollment specifications, minors below 18 and adults above 80 years of age are ineligible for this clinical trial."

Answered by AI

Is this medical trial actively seeking participants at the moment?

"Affirmative. The information on clinicaltrials.gov reveals that this research is actively recruiting patients, and it was initially posted on December 4th 2018 before its last update on February 18th 2022. A total of 70 participants need to be enrolled from one trial site."

Answered by AI

What is the aggregate headcount of participants in this trial?

"Affirmative. According to the information available on clinicaltrials.gov, this medical test is still looking for patients; it was initially published on December 4th 2018 and recently updated February 18th 2022. The study requires 70 participants from one facility only."

Answered by AI

Am I eligible to partake in this clinical exploration?

"Over the age of 18 and under 80, 70 individuals with aphasia are being accepted into this trial. To be eligible for participation they must have native-level fluency in American English prior to their stroke, no history of speech/language or neurological disorders, and at least 6 months since initial injury caused by stroke."

Answered by AI
~11 spots leftby Dec 2024